BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAK7. A total of 38 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,883,901 | -2.8% | 76,286,000 | 0.0% | 2.06% | -4.4% |
| Q2 2023 | $77,072,118 | -3.7% | 76,286,000 | -0.1% | 2.16% | -2.0% |
| Q1 2023 | $80,060,298 | -3.7% | 76,393,000 | -0.8% | 2.20% | +3.6% |
| Q4 2022 | $83,172,605 | +8.2% | 77,043,000 | 0.0% | 2.12% | +9.2% |
| Q3 2022 | $76,896,000 | +0.1% | 77,043,000 | +0.2% | 1.94% | +4.3% |
| Q2 2022 | $76,828,000 | -0.7% | 76,920,000 | 0.0% | 1.86% | +174.1% |
| Q1 2022 | $77,403,000 | +24.1% | 76,920,000 | +29.3% | 0.68% | +31.3% |
| Q4 2021 | $62,365,000 | +69.9% | 59,503,000 | +63.0% | 0.52% | +49.7% |
| Q3 2021 | $36,713,000 | +48.8% | 36,500,000 | +49.0% | 0.35% | +49.1% |
| Q2 2021 | $24,670,000 | – | 24,500,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 50,586 | $50,777,000 | 3.39% |
| MACKAY SHIELDS LLC | 76,920,000 | $76,828,000 | 1.86% |
| Sonora Investment Management Group, LLC | 8,300,000 | $8,336,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 37,527,000 | $37,482,000 | 0.66% |
| LOOMIS SAYLES & CO L P | 2,274,521 | $188,489,000 | 0.35% |
| Allianz Asset Management GmbH | 118,270,000 | $118,591,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,143,000 | $3,141,000 | 0.08% |
| THRIVENT FINANCIAL FOR LUTHERANS | 14,900,000 | $14,807,000 | 0.04% |
| Jefferies Group LLC | 2,848,000 | $2,831,408 | 0.02% |
| FORESIGHT CAPITAL MANAGEMENT ADVISORS, INC. | 14,000 | $14,000 | 0.02% |